Pfizer Submits New Pediatric Data For Lipitor(R) (Atorvastatin) To The European Medicines Agency (EMEA)
Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission.
People who read this also read
- Pfizer Inc. Affirms Confidence In Its Hormone Therapy Medicines As Important Treatment Options
In connection with the New York Times' recent coverage of hormone therapy1, Pfizer Inc. released important facts and context to respond to the newspaper's account. Pfizer believes the coverage is base... - ChemGenex’s Marketing Authorization Application For Omacetaxine Mepesuccinate Validated By The European Medicines Agency
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced that the European Medicines Agency ("EMEA") has determined that the Marketing Authorization Application ("MAA") for omacetaxine mepesuccinate for ... - The Retrograde Aortic Arch in the Hybrid Approach to Hypoplastic Left Heart Syndrome [ORIGINAL ARTICLES: PEDIATRIC CARDIAC]
Conclusions Clinically important RAAO occurred in 24% of the hypoplastic left heart syndrome patients in this series. If RAAO is detected at birth or early interstage, a Norwood operation is now favor... - Early and Intermediate Outcome After Anatomic Repair of Congenitally Corrected Transposition of the Great Arteries [ORIGINAL ARTICLES: PEDIATRIC CARDIAC]
Conclusions Senning/arterial switch operations can be performed with excellent intermediate-term outcomes in patients with lesions previously thought to confer higher risk. Candidates for Senning/Rast... - Pfizer Offers First Look Inside Its Post-Merger Pipeline
Pfizer gave its first pipeline update since it took over Wyeth in October. Bottom line: The company now has has about 500 products somewhere along the path between early-stage human trials and registr... - Ginkgo herbal medicines may increase seizures in people with epilepsy
Restrictions should be placed on the use of Ginkgo biloba (G. biloba) — a top-selling herbal remedy — because of growing scientific evidence that Ginkgo may increase the risk of seizures in people wit... - New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas
Pfizer Inc. provided an update to its pipeline for the first time since the close of the acquisition of Wyeth in October, 2009. The new development pipeline, composed of assets from both legacy compan... - Pfizer, Like Much of Big Pharma, Pushes Further Into Generics
The distance between Big Pharma and the generic drugs business keeps getting narrower. Under a deal with an Indian drugs shop Strides Arcolab, Pfizer will add some 40 off-patent drugs, including many ... - European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Pfizer Inc. announced that the European Commission has approved Revatio® (sildenafil) solution for injection for patients who are currently prescribed oral Revatio and who are temporarily unable to ta... - Proposals To Dispense More Generic Medicines, UK
Proposals that would allow the dispensing of generic medicines instead of branded medicines in primary care, resulting in long term savings for the NHS, were set out today by the Department of Health....
